ZA200203077B - Ciclesonide contained pharmaceutical composition for application to mucosa. - Google Patents

Ciclesonide contained pharmaceutical composition for application to mucosa.

Info

Publication number
ZA200203077B
ZA200203077B ZA200203077A ZA200203077A ZA200203077B ZA 200203077 B ZA200203077 B ZA 200203077B ZA 200203077 A ZA200203077 A ZA 200203077A ZA 200203077 A ZA200203077 A ZA 200203077A ZA 200203077 B ZA200203077 B ZA 200203077B
Authority
ZA
South Africa
Prior art keywords
mucosa
application
pharmaceutical composition
contained pharmaceutical
ciclesonide
Prior art date
Application number
ZA200203077A
Other languages
English (en)
Inventor
Atsuhiro Nagano
Yoshihisa Nishibe
Kazuya Takanashi
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200203077(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of ZA200203077B publication Critical patent/ZA200203077B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200203077A 1999-10-20 2002-04-18 Ciclesonide contained pharmaceutical composition for application to mucosa. ZA200203077B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29818599 1999-10-20

Publications (1)

Publication Number Publication Date
ZA200203077B true ZA200203077B (en) 2003-02-26

Family

ID=17856327

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203077A ZA200203077B (en) 1999-10-20 2002-04-18 Ciclesonide contained pharmaceutical composition for application to mucosa.

Country Status (36)

Country Link
US (1) US6767901B1 (cs)
EP (1) EP1225902B1 (cs)
JP (1) JP4264211B2 (cs)
KR (1) KR100722209B1 (cs)
CN (2) CN1379674B (cs)
AR (1) AR026072A1 (cs)
AT (1) ATE285779T1 (cs)
AU (1) AU781895B2 (cs)
BG (1) BG65818B1 (cs)
BR (1) BRPI0014878B8 (cs)
CA (1) CA2388322C (cs)
CO (1) CO5261494A1 (cs)
CZ (1) CZ297779B6 (cs)
DE (1) DE60017175T2 (cs)
DK (1) DK1225902T3 (cs)
EA (1) EA006015B1 (cs)
ES (1) ES2234681T3 (cs)
HK (2) HK1050858A1 (cs)
HR (1) HRP20020346B1 (cs)
HU (1) HU228893B1 (cs)
IL (2) IL148691A0 (cs)
ME (1) ME00567B (cs)
MX (1) MXPA02003974A (cs)
MY (1) MY136987A (cs)
NO (1) NO327444B1 (cs)
NZ (1) NZ518298A (cs)
PE (1) PE20010712A1 (cs)
PL (1) PL199702B1 (cs)
PT (1) PT1225902E (cs)
RS (1) RS50310B (cs)
SI (1) SI1225902T1 (cs)
SK (1) SK286196B6 (cs)
TR (1) TR200200841T2 (cs)
TW (1) TWI225788B (cs)
WO (1) WO2001028562A1 (cs)
ZA (1) ZA200203077B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
RS57455B1 (sr) * 2002-07-02 2018-09-28 Astrazeneca Ab Sterilna vodena suspenzija koja sadrži ciklezonid
US7221586B2 (en) 2002-07-08 2007-05-22 Micron Technology, Inc. Memory utilizing oxide nanolaminates
JP2005537347A (ja) * 2002-07-26 2005-12-08 エフ エム シー コーポレーション 微結晶質セルロースの製造
WO2004019955A1 (en) * 2002-08-30 2004-03-11 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
US7879833B2 (en) * 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
AU2005235384B2 (en) * 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
US20080027034A1 (en) * 2004-09-10 2008-01-31 Shah Tushar P Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
MX2010009961A (es) * 2008-03-14 2010-09-30 Cephalon Inc Composicion transmucosica mejorada y forma de dosificacion.
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
EP1050299A4 (en) 1998-01-22 2007-05-02 Santen Pharmaceutical Co Ltd SUSPENSION COLLYRE OF FLUOROMETHOLONE
SE514128C2 (sv) 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Also Published As

Publication number Publication date
CN101869570B (zh) 2012-10-10
EP1225902B1 (en) 2004-12-29
YU28002A (sh) 2004-11-25
CZ20021238A3 (cs) 2002-07-17
DE60017175D1 (de) 2005-02-03
CN101869570A (zh) 2010-10-27
KR100722209B1 (ko) 2007-05-29
AU781895B2 (en) 2005-06-23
BRPI0014878B8 (pt) 2021-05-25
RS50310B (sr) 2009-09-08
US6767901B1 (en) 2004-07-27
DK1225902T3 (da) 2005-05-02
CN1379674B (zh) 2014-10-29
BG65818B1 (bg) 2010-01-29
DE60017175T2 (de) 2005-12-29
NO327444B1 (no) 2009-06-29
SI1225902T1 (en) 2005-06-30
PE20010712A1 (es) 2001-07-12
EP1225902A1 (en) 2002-07-31
ME00567A (en) 2011-12-20
EA006015B1 (ru) 2005-08-25
KR20020059627A (ko) 2002-07-13
NZ518298A (en) 2003-11-28
ATE285779T1 (de) 2005-01-15
MXPA02003974A (es) 2003-09-25
CO5261494A1 (es) 2003-03-31
CA2388322C (en) 2007-09-18
AU7953100A (en) 2001-04-30
BRPI0014878B1 (pt) 2015-08-11
CZ297779B6 (cs) 2007-03-28
IL148691A0 (en) 2002-09-12
JP4264211B2 (ja) 2009-05-13
BR0014878A (pt) 2002-06-11
MY136987A (en) 2008-12-31
ES2234681T3 (es) 2005-07-01
CN1379674A (zh) 2002-11-13
CA2388322A1 (en) 2001-04-26
AR026072A1 (es) 2002-12-26
HUP0203339A3 (en) 2004-07-28
BG106512A (bg) 2002-12-29
HK1050858A1 (zh) 2003-07-11
PT1225902E (pt) 2005-05-31
HRP20020346B1 (en) 2011-06-30
NO20021898L (no) 2002-04-22
HU228893B1 (hu) 2013-06-28
HUP0203339A2 (hu) 2003-02-28
IL148691A (en) 2006-12-10
EA200200375A1 (ru) 2002-10-31
TWI225788B (en) 2005-01-01
JP2003512329A (ja) 2003-04-02
HRP20020346A2 (en) 2004-02-29
NO20021898D0 (no) 2002-04-22
PL356191A1 (en) 2004-06-14
TR200200841T2 (tr) 2002-07-22
PL199702B1 (pl) 2008-10-31
SK286196B6 (sk) 2008-05-06
WO2001028562A1 (en) 2001-04-26
SK6922002A3 (en) 2002-09-10
ME00567B (me) 2011-12-20
HK1149719A1 (en) 2011-10-14

Similar Documents

Publication Publication Date Title
HK1149719A1 (en) Ciclesonide contained pharmaceutical composition for application to mucosa
HK1045650A1 (en) Pharmaceutical composition.
HUP0202513A3 (en) Betha-carboline pharmaceutical compositions
HUP0204372A3 (en) Pharmaceutical compositions providing enhanced drug concentrations
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
ZA200203486B (en) Novel pharmaceutical compositions.
HUP0203597A3 (en) Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use
ZA200000857B (en) Pharmaceutical composition.
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
GB9904163D0 (en) Pharmaceutical compositions
MXPA02003975A (es) Composicion farmaceutica aucosa que contiene ciclesonida.
GB9911017D0 (en) Pharmaceutical compositions
AU2932699A (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
GB9904911D0 (en) Pharmaceutical compositions
GB9902227D0 (en) Pharmaceutical composition for topical administration
GB9902651D0 (en) Pharmaceutical compositions
GB9910671D0 (en) Improved pharmaceutical composition
GB9916210D0 (en) Pharmaceutical composition
GB9916413D0 (en) Pharmaceutical composition
HU9900587D0 (en) New pharmaceutical composition
GB9908636D0 (en) Novel pharmaceutical composition
GB9909297D0 (en) Novel pharmaceutical composition
GB9909073D0 (en) Novel pharmaceutical composition
GB9908643D0 (en) Novel pharmaceutical composition